ClinConnect ClinConnect Logo
Search / Trial NCT06872060

The Effects of Glucagon on Renal Regional Blood Flow in Humans Measured by Magnetic Resonance.

Launched by BISPEBJERG HOSPITAL · Mar 6, 2025

Trial Information

Current as of April 23, 2025

Not yet recruiting

Keywords

ClinConnect Summary

No description provided

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • Normal health confirmed through; Interview and Medical examination
  • Normal values with respect to blood concentrations of fasting plasma glucose, fasting plasma total cholesterol, fasting triglycerides, HDL, LDL, creatinine, liver function tests, and electrolytes
  • Informed consent
  • Exclusion Criteria:
  • Immunosuppressive treatment in the previous 12 months
  • Alcohol abuse
  • Medical treatment with oral glucocorticoids, dipeptidyl peptidase-4 (DPP-4) inhibitors, or GLP-1 receptor agonists, which, in the opinion of the principal investigator, may interfere with glucose metabolism
  • Use of lithium
  • Medical treatment that affects insulin secretion or the renin-angiotensin-aldosterone system
  • Liver disease (ALT \> 2x normal value)
  • Renal impairment (serum creatinine \> 130 µM and/or albuminuria)
  • Individuals with severe claustrophobia
  • Individuals with MR-incompatible foreign bodies
  • Individuals with hypertension

About Bispebjerg Hospital

Bispebjerg Hospital is a leading healthcare institution located in Copenhagen, Denmark, renowned for its commitment to innovative medical research and clinical excellence. As a key sponsor of clinical trials, the hospital focuses on advancing healthcare by exploring novel therapies and treatment protocols across various medical disciplines. With a multidisciplinary team of experienced researchers and clinicians, Bispebjerg Hospital aims to enhance patient outcomes through rigorous scientific inquiry and evidence-based practices, while fostering collaboration with academic institutions and industry partners to drive progress in the medical field.

Locations

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported